Legend Biotech CorpEigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 19.05 USD | 39,27 USD | 16,24 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 52,1 USD | 11 | 10 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 193.439.792 | 17,34 | 5,56 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Legend Biotech Corp
Mitarbeiter 3.100
Handelsplatz NASDAQ
Ticker Symbol LEGN
IPO Datum 2020-06-05
Adresse 2101 Cottontail Lane, Somerset, NJ, United States, 08873
Webseite https://legendbiotech.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Carlos Santos | Chief Financial Officer |
| 2 | Ms. Jessie Yeung M.B.A. | Vice President of Finance, Investor & Public Relations |
| 3 | Mr. James Pepin J.D. | General Counsel |
| 4 | Ms. Ananda Elizabeth Martin Esq., J.D. | Global Compliance Officer |
| 5 | Surabhi Verma | Manager of Investor Relations & Corporate Communications |
| 6 | Ms. Joanne Choi | Senior Manager of Investor Relations |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | FMR Inc | 0,00% | 0,00 Mio. USD |
| 2 | Deerfield Management Co | 0,00% | 0,00 Mio. USD |
| 3 | Suvretta Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 4 | Hillhouse Capital Advisors, Ltd. | 0,00% | 0,00 Mio. USD |
| 5 | Westfield Capital Management Company, L.P. | 0,00% | 0,00 Mio. USD |
| 6 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 7 | Point72 Asset Management, L.P. | 0,00% | 0,00 Mio. USD |
| 8 | Artisan Partners Limited Partnership | 0,00% | 0,00 Mio. USD |
| 9 | Assenagon Asset Management SA | 0,00% | 0,00 Mio. USD |
| 10 | Two Sigma Investments LLC | 0,00% | 0,00 Mio. USD |
| 11 | Kynam Capital Management, LP | 0,00% | 0,00 Mio. USD |
| 12 | Acadian Asset Management LLC | 0,00% | 0,00 Mio. USD |
| 13 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 14 | The Goldman Sachs Group Inc | 0,00% | 0,00 Mio. USD |
| 15 | Davern Capital Partners, L.P. | 0,00% | 0,00 Mio. USD |
| 16 | Patient Square Capital LP | 0,00% | 0,00 Mio. USD |
| 17 | Matthews International Cap Mgmt LLc | 0,00% | 0,00 Mio. USD |
| 18 | Hudson Bay Capital Management LP | 0,00% | 0,00 Mio. USD |
| 19 | Johnson & Johnson | 0,00% | 0,00 Mio. USD |
| 20 | IvyRock Asset Management (HK) Ltd | 0,00% | 0,00 Mio. USD |